Letter to the Editor: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy.
Lu T, Zhang J, Li H, Li G, Yin X, Yu J, Zheng Y, Liu Z, Wang Y, Chen D, Pan Y, Ding T, Zhang Y, Yang Z, Yuan Z, Zhang G, Fan Q, Wang X.
Lu T, et al. Among authors: pan y.
Hepatology. 2024 Apr 1;79(4):E123-E124. doi: 10.1097/HEP.0000000000000733. Epub 2023 Dec 25.
Hepatology. 2024.
PMID: 38147319
No abstract available.